T5	Exp 373 383	the 3' end
T6	Exp 387 400	the IgH locus
T7	Exp 482 484	it
T8	Exp 614 616	it
T9	Exp 769 771	it
T10	Exp 657 661	that
T11	Exp 810 814	that
T12	Exp 409 428	the latter elements
T13	Exp 430 449	the IgH 3' enhancer
T14	Exp 693 711	the c-myc oncogene
T15	Exp 746 759	the IgH locus
T16	Exp 795 809	the mechanisms
T17	Exp 859 861	We
T18	Exp 984 988	When
T19	Exp 1024 1029	which
T20	Exp 1030 1037	the IgH
T21	Exp 1122 1131	the level
T22	Exp 1155 1157	we
T23	Exp 1163 1167	that
T24	Exp 1218 1225	the IgH
T25	Exp 1282 1284	we
T26	Exp 1297 1301	that
T27	Exp 1412 1417	which
T28	Exp 1463 1474	the binding
T29	Exp 1519 1544	the high expression level
T30	Exp 1573 1597	the parental MPC11 cells
T31	Exp 1607 1633	the t(12;15) translocation
T32	Exp 1656 1667	the hybrids
T33	Exp 1815 1819	that
T34	Exp 1727 1746	the IgH 3' enhancer
T35	Exp 1828 1872	the cell-specific and developmental activity
T36	Exp 1876 1888	the enhancer
R7	Coref Anaphora:T7 Antecedent:T37
R8	Coref Anaphora:T8 Antecedent:T38
R9	Coref Anaphora:T9 Antecedent:T38
R10	Coref Anaphora:T10 Antecedent:T39
R11	Coref Anaphora:T11 Antecedent:T16
R12	Coref Anaphora:T19 Antecedent:T40
R13	Coref Anaphora:T33 Antecedent:T41
T1	Protein 59 64	c-myc
T2	Protein 167 172	c-myc
T3	Protein 697 702	c-myc
T4	Protein 1548 1553	c-myc
T37	Exp 457 476	particular interest
T38	Exp 583 601	some human Burkitt
T39	Exp 652 655	LCR
T40	Exp 989 1019	mouse MPC11 plasmacytoma cells
T41	Exp 1785 1814	several transcription factors
